Facebook
Twitter

Home
About
- Our Team
- Careers
News
Contact

Products
Services
- Mass Spectrometric Imaging
Technology
Resources
Menu Menu

AmberGen awarded Phase I SBIR grant for the application of photocleavable bead technology to glycomics

September 2012/in News /by Kenneth Rothschild

Share this entry

Share on Facebook
Share on Twitter
Share on WhatsApp
Share on LinkedIn
Share on Tumblr
Share by Mail

https://www.ambergen.com/wp-content/uploads/logo-retina.png 0 0 Kenneth Rothschild https://www.ambergen.com/wp-content/uploads/logo-retina.png Kenneth Rothschild2012-09-27 13:44:382016-11-10 12:44:45AmberGen awarded Phase I SBIR grant for the application of photocleavable bead technology to glycomics

Menu

Home
About
Technology
Diagnostics
Therapeutics

Products
Services
Resources
News
Contact

Get in Touch

AmberGen, Inc.

313 Pleasant St.

Watertown, MA 02472

(617) 923-9990

Recent News

Recent Posts

AmberGen announces that Dr. Michael Easterling, PhD will join Board of Directors April 2022
AmberGen Announces New Appointments for John Gillespie & Dr. Kenneth J. Rothschild April 2022
AmberGen and Bruker Collaborate on Spatial Biology Imaging Reagents for MALDI-Immunohistochemistry (MALDI-IHC) April 2022
Dr. Mark Lim of AmberGen was honored to be an invited keynote speaker at the “Innovation in Mass Spectrometry Imaging Omics” Session March 2022

© 2022 - AmberGen Inc. Website designed in Massachusetts

Scroll to top